Puma Biotechnology Inc (PBYI)
4.86
-0.10
(-2.02%)
USD |
NASDAQ |
May 03, 16:00
4.875
+0.02
(+0.31%)
After-Hours: 20:00
Puma Biotechnology Cash from Operations (Quarterly): 10.46M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.46M |
| September 30, 2023 | 10.62M |
| June 30, 2023 | 3.296M |
| March 31, 2023 | 2.643M |
| December 31, 2022 | 7.683M |
| September 30, 2022 | 17.26M |
| June 30, 2022 | -13.87M |
| March 31, 2022 | -26.90M |
| December 31, 2021 | -5.435M |
| September 30, 2021 | 10.50M |
| June 30, 2021 | -0.074M |
| March 31, 2021 | 15.66M |
| December 31, 2020 | -5.635M |
| September 30, 2020 | 1.72M |
| June 30, 2020 | 16.23M |
| March 31, 2020 | -11.54M |
| December 31, 2019 | 1.566M |
| September 30, 2019 | -7.307M |
| June 30, 2019 | 44.25M |
| March 31, 2019 | -16.13M |
| December 31, 2018 | 7.047M |
| September 30, 2018 | -7.262M |
| June 30, 2018 | -17.64M |
| March 31, 2018 | -6.253M |
| December 31, 2017 | -35.61M |
| Date | Value |
|---|---|
| September 30, 2017 | -54.91M |
| June 30, 2017 | -45.91M |
| March 31, 2017 | -36.04M |
| December 31, 2016 | -40.96M |
| September 30, 2016 | -34.89M |
| June 30, 2016 | -30.81M |
| March 31, 2016 | -35.03M |
| December 31, 2015 | -33.03M |
| September 30, 2015 | -36.87M |
| June 30, 2015 | -34.55M |
| March 31, 2015 | -50.02M |
| December 31, 2014 | -18.46M |
| September 30, 2014 | -24.32M |
| June 30, 2014 | -17.37M |
| March 31, 2014 | -17.05M |
| December 31, 2013 | -13.58M |
| September 30, 2013 | -12.01M |
| June 30, 2013 | -10.97M |
| March 31, 2013 | -18.48M |
| December 31, 2012 | -24.81M |
| September 30, 2012 | -7.644M |
| June 30, 2012 | -8.774M |
| March 31, 2012 | -2.785M |
| December 31, 2011 | -1.641M |
| September 30, 2011 | -0.1432M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-26.90M
Minimum
Mar 2022
44.25M
Maximum
Jun 2019
3.743M
Average
2.643M
Median
Mar 2023
Cash from Operations (Quarterly) Benchmarks
| ADMA Biologics Inc | 17.60M |
| Pfizer Inc | 5.24B |
| Sarepta Therapeutics Inc | -242.08M |
| Immunogen Inc (DELISTED) | 2.77M |
| United Therapeutics Corp | 376.50M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -8.17M |
| Free Cash Flow | 14.37M |
| Free Cash Flow Per Share (Quarterly) | 0.2168 |
| Free Cash Flow to Equity (Quarterly) | 10.05M |
| Free Cash Flow to Firm (Quarterly) | 12.93M |
| Free Cash Flow Yield | 6.22% |